stem cell news 111016-25

kittybruce

, [( Q' @- ~7 j& F1 K4 l* Y% C1 Y( t* A
Voice from last issue:
! [# x- O7 L5 \  N
( K* x2 t! u5 l; l9 @. @- H& |: Z"Our findings demonstrate the potential value of neural stem cells for treating diabetes without gene transfer. This presents an original strategy to overcome the donor shortage which has hindered cell replacement therapy."--Dr Tomoko Kuwabara from the AIST Institute in Tsukuba, Japan.
  l3 f/ B' s5 C1 _% X( ~, v* Z6 {6 u: c% d9 {
"When people are dancing around the answers, you know they're not for real. And then all of a sudden now instead of a few thousand dollars, they want $20,000. The XCell Center in Germany wanted $60,000 - you knew it was a profit center when you started investigating...That's what these clinics do, they prey on your emotion."--Gary Susser, parent-advocates who paved road in the early 2000s by taking their severely disabled son to Mexico for experimental treatments.
( Y4 H3 W  d/ o" M% ]- o5 y$ B9 K5 b1 S( J# F' l
“I don’t think we’re looking at seeing complete repair of the spinal cord, but at least a partial regain of function.” --Jane Lebkowski, Geron’s chief scientific officer.
/ U/ A# h$ \& i  x' C2 o" d& A3 ~8 ]$ L$ {
"We have to ensure that when one takes on gene-replacement therapy in the context of iPS cells, very considerable effort is made to make sure the cells are normal."--Stephen Duncan, a stem-cell biologist at the Medical College of Wisconsin in Milwaukee.
' A+ T' R3 I$ P# [/ n9 W6 g. G! R! V, s: _' x% ^
“These cells are very responsive to cues in their local environment. It’s crucial to select the right type of stem cell, but it’s just as important to create an environment with the molecular signals necessary to produce the type of cell needed for a particular condition or illness.”--Steven Goldman, M.D., Ph.D., professor and chair of the Department of Neurology at the University of Rochester Medical Center.# J2 o# B$ [' R2 }

+ U+ y9 F7 J0 w, n; O" e9 P9 O% V! b: Y% Y; i
This issue:3 s7 N0 x, C& d* ^: U

bathpp2007

嗯